Jefferies Financial Group Comments on HCA Healthcare, Inc.’s Q2 2022 Earnings (NYSE:HCA)

HCA Healthcare, Inc. (NYSE:HCAGet Rating) – Research analysts at Jefferies Financial Group lowered their Q2 2022 earnings per share estimates for HCA Healthcare in a note issued to investors on Monday, April 25th. Jefferies Financial Group analyst B. Tanquilut now forecasts that the company will post earnings of $4.14 per share for the quarter, down from their previous estimate of $4.60. Jefferies Financial Group also issued estimates for HCA Healthcare’s Q3 2022 earnings at $4.18 EPS, Q4 2022 earnings at $4.96 EPS, FY2022 earnings at $17.40 EPS and FY2023 earnings at $18.65 EPS.

A number of other equities analysts have also weighed in on the stock. Credit Suisse Group decreased their price target on shares of HCA Healthcare from $296.00 to $260.00 and set an “outperform” rating on the stock in a report on Monday. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $291.00 to $267.00 and set an “outperform” rating on the stock in a report on Monday. Wells Fargo & Company dropped their price target on shares of HCA Healthcare from $267.00 to $227.00 and set an “equal weight” rating on the stock in a research note on Monday. Truist Financial dropped their target price on shares of HCA Healthcare from $310.00 to $250.00 and set a “buy” rating for the company in a research report on Monday. Finally, Cowen lowered their price objective on shares of HCA Healthcare from $265.00 to $241.00 in a research report on Monday. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $260.64.

Shares of NYSE HCA opened at $214.94 on Wednesday. The firm has a market cap of $64.92 billion, a P/E ratio of 10.11, a price-to-earnings-growth ratio of 1.48 and a beta of 1.60. The firm’s 50 day moving average price is $255.15 and its 200 day moving average price is $248.48. HCA Healthcare has a 1 year low of $197.41 and a 1 year high of $279.02. The company has a debt-to-equity ratio of 23.06, a quick ratio of 1.21 and a current ratio of 1.41.

HCA Healthcare (NYSE:HCAGet Rating) last announced its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $4.25 by ($0.13). HCA Healthcare had a return on equity of 303.35% and a net margin of 11.84%. The firm had revenue of $14.95 billion for the quarter, compared to analyst estimates of $14.72 billion. During the same quarter last year, the business posted $4.14 EPS. The firm’s revenue was up 6.9% compared to the same quarter last year.

HCA Healthcare announced that its Board of Directors has approved a stock repurchase plan on Thursday, January 27th that allows the company to buyback $8.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 10.9% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Investors of record on Thursday, June 16th will be issued a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a dividend yield of 1.04%. The ex-dividend date is Wednesday, June 15th. HCA Healthcare’s dividend payout ratio is currently 10.54%.

In related news, insider A Bruce Moore, Jr. sold 20,633 shares of the stock in a transaction dated Wednesday, February 16th. The shares were sold at an average price of $244.01, for a total transaction of $5,034,658.33. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Joseph A. Sowell III sold 11,522 shares of the stock in a transaction dated Friday, March 11th. The stock was sold at an average price of $269.00, for a total transaction of $3,099,418.00. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. lifted its holdings in HCA Healthcare by 1.9% during the 4th quarter. BlackRock Inc. now owns 16,377,032 shares of the company’s stock worth $4,207,588,000 after purchasing an additional 313,091 shares during the last quarter. Sanders Capital LLC raised its holdings in HCA Healthcare by 16.9% in the 4th quarter. Sanders Capital LLC now owns 9,448,037 shares of the company’s stock valued at $2,650,774,000 after acquiring an additional 1,365,582 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of HCA Healthcare by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,793,750 shares of the company’s stock worth $971,719,000 after buying an additional 10,724 shares in the last quarter. Norges Bank bought a new stake in HCA Healthcare during the 4th quarter worth $596,396,000. Finally, Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 1.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,292,237 shares of the company’s stock valued at $556,372,000 after buying an additional 39,947 shares during the last quarter. Institutional investors own 66.36% of the company’s stock.

HCA Healthcare Company Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.